Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to ...
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to ...
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care ...
What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der ...
Follow-up results from the phase 3 EMBER-3 study showed that, as a monotherapy, Inluriyo demonstrated a 38% reduction in the ...
Galderma’s Nemluvio (nemolizumab) has shown rapid relief of itch, as well as improvement in sleep, in patients with atopic ...
Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We ...
Biopharma leaders anticipate a significant impact from their AI investments. In fact, our research shows 86% forecast a 5%+ sales uplift and 55% expect 10%+ cost savings. However, for many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback